润达医疗: insider trades · France · AMF SSE:603108 FR FR · AMF Mcap 9.0Bn€
Discover the full management transaction log of 润达医疗, a listed issuer based in France. Shares are listed on FR FR, under the oversight of AMF. Market capitalisation: €9bn. The latest transaction was filed on 14 January 2026 — Sale. Among the most active insiders: 陈政. Every trade is openly available.
Financial data FY ended December 2025 · cache
Income statement
Revenue 7.00 Bn€
Gross profit 1.50 Bn€ 21% margin
Net income −548.4 M€ -7.8% margin
Balance sheet & cash
Market cap 9.02 Bn€
Total debt 6.77 Bn€
Free Cash Flow 386.7 M€
Last declaration on 14 January 2026
Declarations 10 total
Executives ● Sale22 SSE
2,678,999 shares
SSE:273000000111088420 · 14 Jan 2026
Executives ● Sale7 SSE
166,400 shares
SSE:173000007312632640 · 8 Feb 2024
Executives ● Sale7 SSE
130,000 shares
SSE:173000007005068540 · 13 Oct 2023
Executives ● Sale7 SSE
1,267,700 shares
SSE:173000006285450980 · 16 Feb 2023
Executives ● Sale7 SSE
124,500 shares
SSE:173000006064034500 · 21 Nov 2022
Executives ● Sale7 SSE
148,200 shares
SSE:173000004478502750 · 11 Jun 2021
Executives ● Sale7 SSE
160,000 shares
SSE:173000004478509250 · 10 Jun 2021
Executives ● Sale7 SSE
70,000 shares
SSE:173000004467327780 · 8 Jun 2021
Executives ● Sale7 SSE
100,000 shares
SSE:173000004469902880 · 7 Jun 2021
Executives ● Sale7 SSE
20,000 shares
SSE:173000004459196930 · 3 Jun 2021